University of Queensland of St. Lucia obtains United States patent.

From: BIOTECH Patent News | Date: July 1, 2007 | Copyright information

University of Queensland of St. Lucia (Queensland, Australia) has patented enzymes that convert sucrose to isomaltulose. More particularly, the present invention discloses novel sucrose isomerases, polynucleotides encoding these sucrose isomerases, methods for isolating such polynucleotides and nucleic acid constructs that express these polynucleotides. Also disc...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Nuvelo obtains United States patent.(Brief Article)
BIOTECH Patent News ; Nuvelo, Inc. (Sunnyvale, CA) has patented polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and
Northwestern University obtains United States patent.(polypeptide components of the mammalian circadian clock)(Brief Article)
BIOTECH Patent News ; Northwestern University (Evanston, IL) has patented isolated and purified polypeptide components of the mammalian circadian clock, polynucleotides that encode those polypeptides, expression vectors containing those polynucleotides, host cells transformed with those expression vectors, a process of
Mendel Biotechnology obtains United States patent.
BIOTECH Patent News ; Mendel Biotechnology, Inc. (Hayward, CA) has patented plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared
The actions of polynucleotides on effector stage cloned murine T-helper cells differ in each subset and depend on antigen concentration
The Journal of Nutrition ; The Actions of Polynucleotides on Effector Stage Cloned Murine T-Helper Cells Differ in Each Subset and Depend on Antigen Concentration'2 ABSTRACT Polynucleotides enhance T-helper (Th) cell-mediated humoral immune responses in naive resting Th cells, B cells, and antigen-presenting cells (APC) from
Smithkline Beecham obtains United States patent.(HE8CH90 polypeptides and polynucleotides)(Brief Article)
BIOTECH Patent News ; Smithkline Beecham Corporation (Philadelphia, PA) has patented HE8CH90 polypeptides and polynucleotides and method, for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HE8CH90 polypeptides and polynucleotides in the design of protocols
Smithkline Beecham obtains United States patent.(#6232441)(Brief Article)
BIOTECH Patent News ; Smithkline Beecham Corporation (Philadelphia, PA) has patented PIGR-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PIGR-1 polypeptides and polynucleotides in the design of protocols for
Vical granted key DNA vaccine patent in Europe.(Brief Article)
BIOTECH Patent News ; Vical, Inc. (San Diego, CA) announced that European Patent EP0737750, entitled Expression of Exogenous Polynucleotide Sequences in a Vertebrate, has been granted to Vical. This patent is part of a family of patents based on the company's discovery that tissues can take up polynucleotides, such as
Smithkline Beecham obtains United States patent.(SmithKline Beecham Corp.)(Brief Article)
BIOTECH Patent News ; Smithkline Beecham Corporation (Philadelphia, PA) has patented HNEAA81 polypeptides and polynucleotides, and methods for identifying agonists and antagonists of the interaction of the HNEAA81 receptor and its ligands in the design of protocols for the treatment of infections. (US 6162899)
Millennium applies for patent.
BIOTECH Patent News ; Millennium Pharmaceuticals, Inc. (Cambridge, MA) has applied for a patent covering myocardium secreted protein-5 polynucleotides, used to modulate a variety of cellular processes. (US Appl. 163285; WO Publication 9967385)
GENSET obtains United States patent.(patents prostate cancer gene)(Brief Article)
BIOTECH Patent News ; GENSET (Paris, France) has patented PG1, a gene associated with prostate cancer, and polynucleotides including biallelic markers derived from PG1 and from flanking genomic regions. (US 6265546)